Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9508-9514

  Kirby, Ian ^a   Davison, Elizabeth ^a   Beavil, Andrew J ^b   Soh, Cecilia P C ^a   Wickham, Thomas J ^c   Roelvink, Peter W ^c   Kovesdi, Imre ^c   Sutton, Brian J ^b   Santis, George ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; VIRUS RECEPTOR;

ADENOVIRUS; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; SURFACE PLASMON RESONANCE; VIRUS MUTATION;

EID: 0032829560     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9508-9514.1999     Document Type: Article

References (41)

1. Bai, M., L. Campisi, and P. Freimith. 1994. Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2. J. Virol. 68:5925-5932.
2. Belin, M., and P. A. Boulanger. 1994. Involvement of cellular adhesion sequences in the attachment of adenovirus to the HeLa cell surface. J. Gen. Virol. 74:1485-1497.
3. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
4. Bergelson, J. M., A. Krithivas, L. Cell, G. Droguett, M. S. Horwitz, T. J. Wickham, R. L. Crowell, and R. W. Finberg. 1998. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J. Virol. 72:415-419.
5. Cook, J. P. D., A. J. Henry, J. M. McDonnell, R. J. Owens, B. J. Sutton, and H. J. Gould. 1997. Identification of contact residues in the IgE binding sites of human FceRIa. Biochemistry 36:15579-15588.
6. Davison, E., R. M. Diaz, I. R. Hart, G. Santis, and J. F. Marshall. 1997. Integrin α5β1-mediated adenovirus infection is enhanced by the integrin activating antibody TS2/16. J. Virol. 71:6204-6207.
7. Davison, E., I. Kirby, T. Elliot, and G. Santis. 1999. The human HLA-AO201 allele, when expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber. J. Virol. 73:4513-4517.
8. Defer, C., M.-T. Belin, M.-L. Caillet-Boudin, and P. A. Boulanger. 1990. Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J. Virol. 64:3561-3673.
9. Douglas, J., B. Rogers, M. Rosenfeld, S. Michael, M. Feng, and D. Curiel. 1996. Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotechnol. 14:1574-1578.
10. Fender, P., A. Kidd, R. Brebant, M. Oberg, E. Drouet, and J. Chroboczek. 1995. Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber. Virology 214:110-117.
11. Freimuth, P., K. Springer, C. Berard, J. Hainfeld, M. Bewley, and J. Flanagan. 1999. Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12. J. Virol. 73:1392-1398.
12. Gall, J., A. Kass-Eisler, L. Leinwand, and E. Falck-Pedersen. 1996. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J. Virol. 70:2116-2123.
13. Graham, F., and L. Prevec. 1992. Adenovirus based expression vectors and recombinant veccines, p. 363-390. In R. Ellis (ed.), Vaccine: new approaches to immunological problems. Butterworth-Heinemann, London, United Kingdom.
14. Green, N. M., N. G. Wringley, W. C. Russell, S. R. Martin, and A. D. MacLachlan. 1983. Evidence of a repeating cross-beta sheet structure in the adenovirus fibre. EMBO J. 2:1357-1365.
15. Hennache, B., and P. Boulanger. 1977. Biochemical study of KB-cell receptor for adenovirus. Biochem. J. 166:237-247.
16. Henry, A. J., J. P. D. Cook, J. M. McDonnell, G. A. McCay, J. Shi, B. J. Sutton, and H. J. Gould. 1997. Identification of contact residues in the IgE binding site of human Fcepsilon RIalpha. Biochemistry 36:15568-15578.
17. Henry, L. J., D. Xia, M. E. Wilke, J. Deisenhofer, and R. D. Gerard. 1994. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J. Virol. 68:5239-5246.
18. Hong, S. S., L. Karayan, J. Tournier, D. T. Curiel, and P. A. Boulanger. 1997. Adenovirus type 5 fiber knob binds to MHC class I alpha 2 domain at the surface of human epithelial and B lymphoblatoid cells. EMBO J. 16:2294-2306.
19. Hubbard, S. J., and J. M. Thornton. 1999. NACCESS computer program. University College London, London, United Kingdom.
20. Karayan, L., B. Gay, J. Gerfaux, and P. A. Boulanger. 1994. Oligomerization of recombinant penton base of adenovirus type 2 and its assembly with fiber in baculovirus-infected cells. Virology 202:782-795.
21. Krashnykh, V., I. Dmitriev, G. Mikheeva, C. R. Millers, N. Belousova, and T. D. Curiel. 1998. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 72:1844-1852.
22. Krasnykh, V., G. Mikheeva, J. Douglas, and D. Curiel. 1996. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70:6839-6846.
23. Legrand, V., D. Spehner, Y. Schlesinger, N. Settelen, A. Pavirani, and M. Mehtali. 1999. Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber. J. Virol. 73:907-913.
24. Levine, A., and H. Ginsberg. 1967. Mechanism by which fiber antigen inhibit multiplication of type 5 adenovirus. J. Virol. 1:747-757.
25. Mautner, V., and H. Willcox. 1974. Adenovirus antigens: a model system in mice for subunit vaccination. J. Gen. Virol. 25:325-336.
26. Michael, S. I., J. S. Hong, D. T. Curiel, and J. A. Engler. 1995. Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2:660-668.
27. Novelli, A., and P. A. Boulanger. 1991. Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185:365-376.
28. Provencher, S. W., and J. Glockner. 1981. Estimation of globular protein secondary structure from circular dichroism. Biochemistry 20:33-37.
29. Roelvink, P. W., A. Lizonova, J. G. M. Lee, Y. Li, J. M. Bergelson, R. W. Finberg, D. E. Brough, I. Kovesdi, and T. J. Wickham. 1998. The coxsackie-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72:7909-7915.
30. Santis, G., V. Legrand, S. Hong, E. Davison, I. Kirby, J.-L. Imler, J. M. Bergelson, R. W. Finberg, M. Mehtali, and P. A. Boulanger. 1999. Molecular determinants and serotype specificity of AdS fiber binding to its high affinity receptor CAR. J. Gen. Virol. 80:1519-1527.
31. Svensson, U., R. Persson, and E. Everitt. 1981. Virus-receptor interaction in the adenovirus system: identification of virion attachment proteins of the Hela cell plasma membrane. J. Virol. 38:70-81.
32. Tomko, R., R. Xu, and L. Philipson. 1997. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. 94:3352-3356.
33. Wang, X., and J. M. Bergelson. 1999. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection. J. Virol. 73:2559-2562.
34. Watkins, S. J., V. V. Mesyanzhinov, L. P. Kurochkina, and R. E. Hawkins. 1997. The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery. Gene Ther. 4:1004-1012.
35. Wickham, T. J., P. Roelvink, D. Brough, and I. Kovesdi. 1996. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14:1570-1578.
36. Wickham, T., D. Segal, P. Roelvink, M. Carrion, A. Lizonova, G. Lee, and I. Kovesdi. 1996. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70:6831-6838.
37. Wickham, T. J., E. J. Filardo, D. A. Cheresh, and G. R. Nemerow. 1994. Integrin αvβ5 selectively promotes adenovirus cell membrane permeability. J. Cell Biol. 127:257-264.
38. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins αv β3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
39. Wickham, T. J., D. M. Tzeng, P. W. Roelvink, Y. Li, G. M. Lee, D. E. Brough, A. Lizonova, and I. Kovesdi. 1997. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71:8221-8229.
40. Wu, G. Y., P. Zhan, L. L. Sze, A. R. Rosenberg, and C. H. Wu. 1994. Incorporation of adenovirus into a ligand-based DNA carrier system results in retenion of original receptor specificity and enhances targeted gene expression. J. Biol. Chem. 269:11542-11546.
41. Xia, D., L. Henry, R. Gerard, and J. Desenhofer. 1994. Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 Å resolution. Structure 2:1259-1270.